DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...

Positron emission tomography (PET) scans create images to show how well organs or tissues in the body are functioning or look for the presence of disease. PET scans are routinely used in combination ...

Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...

Positron emission tomography (PET) represents a unique molecular tool to get in vivo access to a wide spectrum of biological and neuropathological processes, of crucial relevance for neurodegenerative ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

Carmine Stengone, CEO, Contineum (CTNM) Therapeutics. “We expect to be sponsoring up to six clinical trials during the course of the year, with key topline data from our PIPE-791 Phase 1b positron ...

POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered ...